US$ 28.23
glp-1 news oct 16 2025 ISPOR 2025: Exploring reasons for discontinuation Regulating a "Miracle Drug": GLP-1
Description
Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N

Even short-term changes in treatment may have meaningful implications for patients as they navigate the impact of formulary decisions

The neuroscience of depressive disorders: A brief review of the past and some considerations about the future

I.IkleJ

feeling them for yourself is where the real transformation begins
[DOI] [PMC free article] [PubMed] [Google Scholar] 16.Roseberry A.G
